BIOMAT Database Logo BIOMAT Database Logo

Tumor biology of infiltrating lobular carcinoma. Implications for management. 1995

T J Yeatman, and A B Cantor, and T J Smith, and S K Smith, and D S Reintgen, and M S Miller, and N N Ku, and P A Baekey, and C E Cox
Department of Surgery, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, USA.

OBJECTIVE The purpose of this study was to characterize the biologic determinants that affect the behavior and management of infiltrating lobular cancer. METHODS A prospectively accrued data base containing 1548 breast cancer cases was queried for specific pathologic and mammographic features. From this data base, 777 patients treated and followed-up at the H. Lee Moffitt Cancer Center were reviewed, and comparisons were made between the following three histologic subgroups: 661 infiltrating ductal (ID), 42 infiltrating ductal plus infiltrating lobular (ID + IL), and 74 infiltrating lobular (IL). RESULTS Comparisons of the three histologic forms of breast cancer demonstrated the following: 1. At diagnosis tumors with IL components were larger than those with ID components (p < 0.001); in addition, a greater percentage of IL cancers were T3 lesions (14.8%), compared with ID cancers (4.5%). 2. Sizes of IL tumors were underestimated frequently by mammographic examinations when compared with pathologic measurements (p < 0.001). 3. By comparison to ID tumors, increasing IL tumor size is less likely to be associated with an increased number of metastatic lymph nodes per patient (p = 0.09). 4. Infiltrating lobular cancers treated by lumpectomy with cytologic surgical margin analysis more often gave false-negative results than did ID cancers (p < 0.001). 5. Infiltrating lobular cancers treated by lumpectomy required conversion to mastectomy over 2 times more frequently than ID cancers treated by lumpectomy. 6. Mastectomy was performed more frequently than lumpectomy for the treatment of IL versus ID tumors (p = 0.039). CONCLUSIONS Infiltrating lobular cancers are biologically distinct from ID cancers. Although lumpectomy may be performed safely in selected patients, multiple difficulties exist in the management of IL cancer, particularly when breast conservation is chosen.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008327 Mammography Radiographic examination of the breast. 3D-Mammography,Digital Breast Tomosynthesis,Digital Mammography,X-ray Breast Tomosynthesis,3D Mammography,3D-Mammographies,Breast Tomosyntheses, Digital,Breast Tomosyntheses, X-ray,Breast Tomosynthesis, Digital,Breast Tomosynthesis, X-ray,Digital Breast Tomosyntheses,Digital Mammographies,Mammographies,Mammographies, Digital,Mammography, Digital,X ray Breast Tomosynthesis,X-ray Breast Tomosyntheses
D008408 Mastectomy Surgical procedure to remove one or both breasts. Mammectomy,Mammectomies,Mastectomies
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T J Yeatman, and A B Cantor, and T J Smith, and S K Smith, and D S Reintgen, and M S Miller, and N N Ku, and P A Baekey, and C E Cox
Infiltrating lobular carcinoma without lobular carcinoma in situ.
June 1972, Cancer,
T J Yeatman, and A B Cantor, and T J Smith, and S K Smith, and D S Reintgen, and M S Miller, and N N Ku, and P A Baekey, and C E Cox
Infiltrating lobular carcinoma--a comparison of diagnosis, management and outcome with infiltrating duct carcinoma.
October 2004, Breast (Edinburgh, Scotland),
T J Yeatman, and A B Cantor, and T J Smith, and S K Smith, and D S Reintgen, and M S Miller, and N N Ku, and P A Baekey, and C E Cox
Radiology. Infiltrating lobular carcinoma.
October 1999, The Journal of the Arkansas Medical Society,
T J Yeatman, and A B Cantor, and T J Smith, and S K Smith, and D S Reintgen, and M S Miller, and N N Ku, and P A Baekey, and C E Cox
Grading of infiltrating lobular carcinoma.
September 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
T J Yeatman, and A B Cantor, and T J Smith, and S K Smith, and D S Reintgen, and M S Miller, and N N Ku, and P A Baekey, and C E Cox
Infiltrating lobular carcinoma of breast.
March 1956, Canadian Medical Association journal,
T J Yeatman, and A B Cantor, and T J Smith, and S K Smith, and D S Reintgen, and M S Miller, and N N Ku, and P A Baekey, and C E Cox
Conservative surgery for infiltrating lobular breast carcinoma.
January 1997, The British journal of surgery,
T J Yeatman, and A B Cantor, and T J Smith, and S K Smith, and D S Reintgen, and M S Miller, and N N Ku, and P A Baekey, and C E Cox
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.
January 2004, Breast cancer research : BCR,
T J Yeatman, and A B Cantor, and T J Smith, and S K Smith, and D S Reintgen, and M S Miller, and N N Ku, and P A Baekey, and C E Cox
Infiltrating lobular carcinoma: is it different from infiltrating duct carcinoma?
August 1994, Cancer,
T J Yeatman, and A B Cantor, and T J Smith, and S K Smith, and D S Reintgen, and M S Miller, and N N Ku, and P A Baekey, and C E Cox
Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma?
March 1994, Cancer,
T J Yeatman, and A B Cantor, and T J Smith, and S K Smith, and D S Reintgen, and M S Miller, and N N Ku, and P A Baekey, and C E Cox
Sonographic evaluation of infiltrating lobular carcinoma.
February 1999, AJR. American journal of roentgenology,
Copied contents to your clipboard!